Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
President Barack Obama on Wednesday signed legislation into law that averts the majority of the so-called "fiscal cliff.” The law defers decisions on sequestration by two months, meaning that lawmakers will debate sequestration at the same time as they tackle a debate on the overall federal budget plans for 2013 and 2014. The law also “keeps researchers on tenterhooks for at least another two months by delaying mandatory spending cuts that could threaten science funding.”
A new article examines the international military sector's role in global health activities, which "has gained visibility in recent years." According to the article, the military provides support for a range of activities, including “medical research and development to peacekeeping operations while providing normative, technical assistance, and coordinating roles.”
Devex examines possible policy changes that Sen. John Kerry (D-Mass.) will bring to the State Department if confirmed as the next Secretary of State.
Approvals from the US Food and Drug Administration for new drugs hit 16-year high in 2012. The agency approved 39 new drugs in 2012, including a new treatment for multi-drug resistant tuberculosis.
Researchers announced that they have developed a therapeutic vaccine that can temporarily halt the growth of HIV in patients.
There is an alarming rise in resistance to artemisinin in Thailand, which is currently the front-line drug in the treatment of malaria. Doctors fear it could be the start of the global spread of malaria drug resistance, underscoring the need for research into new treatments for the disease.